Mette Gyldenløve

Mette Gyldenløve

Clinical Associate Professor

Member of:

  • Dermatovenerology


Publication year:
All
1 - 5 out of 5Page size: 10
  1. 2022
  2. Published

    Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review

    Gyldenløve, Mette, Alinaghi, F., Zachariae, Claus, Skov, Lone & Egeberg, Alexander, 2022, In: American Journal of Clinical Dermatology. 23, 5, p. 605-613

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy

    Ring, H. C., Egeberg, Alexander, Zachariae, Claus, Thomsen, Simon Francis & Gyldenløve, Mette, 2022, In: British Journal of Dermatology. 187, 5, 2 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  4. Published

    Killing all the birds with one drug–is oral roflumilast a novel treatment option for psoriasis?

    Gyldenløve, Mette & Egeberg, Alexander, 2022, In: Journal of Dermatological Treatment. 33, 6, p. 2782-2783 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Rapid clearing of refractory nummular dermatitis with oral roflumilast therapy

    Gyldenløve, Mette, Zachariae, Claus, Thyssen, Jacob Pontoppidan & Egeberg, Alexander, 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 10, p. e765-e766

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  6. Published

    Rapid improvement of idiopathic aphthous ulcers with oral roflumilast therapy

    Gyldenløve, Mette, Meteran, Howraman, Zachariae, Claus & Egeberg, Alexander, 2022, In: British Journal of Dermatology. 187, 2, p. 258-259 2 p.

    Research output: Contribution to journal › Letter › Research › peer-review

ID: 308239401